Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMGEN INC · Firm: AMGEN, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMGEN INC via AMGEN, INC.
2007 · mid_year · MM
Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare coverage and reimbursement of Erythropoiesis-Stimulating Agents Implementation of Medicaid Drug Rebate provisions of the Deficit Reduction Act of 2005
Intellectual property and process patent issues S. 1145 and S. 1908 – Patent Reform Act of 2007
Source: Senate LDA
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
Intellectual property and process patent issues S. 1145 and S. 1908 – Patent Reform Act of 2007
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
A bill to amend the procedures regarding military recruiter access to secondary school student recruiting information.
Client: AMGEN INC · Firm: AMGEN, INC.
Intellectual property and process patent issues S. 1145 and S. 1908 – Patent Reform Act of 2007
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
H.R. 6257: Access to Life-Saving Medicine Act S. 4016: Access to Life-Saving Medicine Act S. 3807: Enhancing Drug Safety and Innovation Act of 2006 Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement Follow-On-Biologics FDA Drug Safety Oversight
Intellectual Property and Process Patent Issues H.R. 2795: Patent Act of 2005 S. 3818: Patent Reform Act of 2006
H.R. 6257: Access to Life-Saving Medicine Act S. 4016: Access to Life-Saving Medicine Act S. 3807: Enhancing Drug Safety and Innovation Act of 2006 Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement Follow-On-Biologics FDA Drug Safety Oversight
Corporate Tax Issues
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2006 · year_end · YY
Intellectual Property and Process Patent Issues
H.R. 6257: Access to Life-Saving Medicine Act S. 4016: Access to Life-Saving Medicine Act S. 3807: Enhancing Drug Safety and Innovation Act of 2006 Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement Follow-On-Biologics FDA Drug Safety Oversight
Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare and Medicaid Reimbursement H.R. 6111: Tax Relief and Health Care Act of 2006
Corporate Tax Issues
Intellectual Property and Process Patent Issues H.R. 2795: Patent Act of 2005 S. 3818: Patent Reform Act of 2006
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
AMGEN INC via AMGEN, INC.
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2003 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE